Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

A novel SCN5A mutation associated with idiopathic ventricular fibrillation without typical ECG findings of Brugada syndrome.

Akai J, Makita N, Sakurada H, Shirai N, Ueda K, Kitabatake A, Nakazawa K, Kimura A, Hiraoka M.

FEBS Lett. 2000 Aug 11;479(1-2):29-34.

2.

Clinical and electrophysiological characteristics of Brugada syndrome caused by a missense mutation in the S5-pore site of SCN5A.

Itoh H, Shimizu M, Mabuchi H, Imoto K.

J Cardiovasc Electrophysiol. 2005 Apr;16(4):378-83.

PMID:
15828879
3.

A cardiac sodium channel mutation identified in Brugada syndrome associated with atrial standstill.

Takehara N, Makita N, Kawabe J, Sato N, Kawamura Y, Kitabatake A, Kikuchi K.

J Intern Med. 2004 Jan;255(1):137-42.

4.

Genetic analysis of Brugada syndrome in Western Japan: two novel mutations.

Niimura H, Matsunaga A, Kumagai K, Ohwaki K, Ogawa M, Noguchi H, Yonemura K, Saku K.

Circ J. 2004 Aug;68(8):740-6. Erratum in: Circ J. 2004 Oct;68(10):974.

5.

A novel SCN5A mutation, F1344S, identified in a patient with Brugada syndrome and fever-induced ventricular fibrillation.

Keller DI, Huang H, Zhao J, Frank R, Suarez V, Delacrétaz E, Brink M, Osswald S, Schwick N, Chahine M.

Cardiovasc Res. 2006 Jun 1;70(3):521-9. Epub 2006 Mar 3.

PMID:
16616735
6.

Novel mutations in domain I of SCN5A cause Brugada syndrome.

Vatta M, Dumaine R, Antzelevitch C, Brugada R, Li H, Bowles NE, Nademanee K, Brugada J, Brugada P, Towbin JA.

Mol Genet Metab. 2002 Apr;75(4):317-24.

PMID:
12051963
7.

Novel brugada SCN5A mutation leading to ST segment elevation in the inferior or the right precordial leads.

Potet F, Mabo P, Le Coq G, Probst V, Schott JJ, Airaud F, Guihard G, Daubert JC, Escande D, Le Marec H.

J Cardiovasc Electrophysiol. 2003 Feb;14(2):200-3.

PMID:
12693506
8.

Enhanced Na(+) channel intermediate inactivation in Brugada syndrome.

Wang DW, Makita N, Kitabatake A, Balser JR, George AL Jr.

Circ Res. 2000 Oct 13;87(8):E37-43.

9.

[Doubts of the cardiologist regarding an electrocardiogram presenting QRS V1-V2 complexes with positive terminal wave and ST segment elevation. Consensus Conference promoted by the Italian Cardiology Society].

Oreto G, Corrado D, Delise P, Fedele F, Gaita F, Gentile F, Giustetto C, Michelucci A, Padeletti L, Priori S.

G Ital Cardiol (Rome). 2010 Nov;11(11 Suppl 2):3S-22S. Italian.

PMID:
21361048
10.

Sodium channel gene (SCN5A) mutations in 44 index patients with Brugada syndrome: different incidences in familial and sporadic disease.

Schulze-Bahr E, Eckardt L, Breithardt G, Seidl K, Wichter T, Wolpert C, Borggrefe M, Haverkamp W.

Hum Mutat. 2003 Jun;21(6):651-2. Erratum in: Hum Mutat. 2005 Jul;26(1):61.

PMID:
14961552
11.

Genetic analysis of the cardiac sodium channel gene SCN5A in Koreans with Brugada syndrome.

Shin DJ, Jang Y, Park HY, Lee JE, Yang K, Kim E, Bae Y, Kim J, Kim J, Kim SS, Lee MH, Chahine M, Yoon SK.

J Hum Genet. 2004;49(10):573-8. Epub 2004 Aug 26.

PMID:
15338453
12.

A mutant cardiac sodium channel with multiple biophysical defects associated with overlapping clinical features of Brugada syndrome and cardiac conduction disease.

Shirai N, Makita N, Sasaki K, Yokoi H, Sakuma I, Sakurada H, Akai J, Kimura A, Hiraoka M, Kitabatake A.

Cardiovasc Res. 2002 Feb 1;53(2):348-54.

PMID:
11827685
13.

Nucleotide changes in the translated region of SCN5A from Japanese patients with Brugada syndrome and control subjects.

Takahata T, Yasui-Furukori N, Sasaki S, Igarashi T, Okumura K, Munakata A, Tateishi T.

Life Sci. 2003 Apr 11;72(21):2391-9.

PMID:
12639704
14.

Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent.

Dumaine R, Towbin JA, Brugada P, Vatta M, Nesterenko DV, Nesterenko VV, Brugada J, Brugada R, Antzelevitch C.

Circ Res. 1999 Oct 29;85(9):803-9.

15.

A newly characterized SCN5A mutation underlying Brugada syndrome unmasked by hyperthermia.

Mok NS, Priori SG, Napolitano C, Chan NY, Chahine M, Baroudi G.

J Cardiovasc Electrophysiol. 2003 Apr;14(4):407-11.

PMID:
12741714
16.

A novel missense mutation in the SCN5A gene associated with Brugada syndrome bidirectionally affecting blocking actions of antiarrhythmic drugs.

Itoh H, Shimizu M, Takata S, Mabuchi H, Imoto K.

J Cardiovasc Electrophysiol. 2005 May;16(5):486-93.

PMID:
15877619
17.

Mutation-specific effects of lidocaine in Brugada syndrome.

Clancy CE, Wehrens XH.

Int J Cardiol. 2007 Oct 18;121(3):249-52. Epub 2007 Aug 29.

PMID:
17761312
18.

[Novel SCN5A gene mutations associated with Brugada syndrome: V95I, A1649V and delF1617].

Liang P, Liu WL, Hu DY, Li CL, Tao WH, Li L.

Zhonghua Xin Xue Guan Bing Za Zhi. 2006 Jul;34(7):616-9. Chinese.

PMID:
17081365
19.
20.

Efficacy of low-dose bepridil for prevention of ventricular fibrillation in patients with Brugada syndrome with and without SCN5A mutation.

Murakami M, Nakamura K, Kusano KF, Morita H, Nakagawa K, Tanaka M, Tada T, Toh N, Nishii N, Nagase S, Hata Y, Kohno K, Miura D, Ohe T, Ito H.

J Cardiovasc Pharmacol. 2010 Oct;56(4):389-95. doi: 10.1097/FJC.0b013e3181f03c2f.

PMID:
20625312

Supplemental Content

Support Center